Table 3. Characteristics before study... | American Society of Hematology

Table 3.

Characteristics before study transfusions of women with detectable posttransfusion male donor cells

Recipient	Race	HIV risk	Age	Previous HAART use (start day, in relation to T1 transfusion)^3-150	Log₁₀ HIV viral load	CD4 cells/μL	Detection of male cells after transfusion episode
Recipient	Race	HIV risk	Age		Log₁₀ HIV viral load	CD4 cells/μL	T1	T2
NLR-1	Black	Intravenous drug use	47	No	4.7	6	No	Yes
NLR-2	Black	Intravenous drug use	28	−27	3.3	3	No	Yes
NLR-3	Black	Heterosexual	34	−48	5.0	6	No	Yes
NLR-4	White	Heterosexual	45	No	4.7	10	Yes	No
NLR-5	Black	Heterosexual	44	No	4.7	2	No	Yes
LR-1	White	Heterosexual	31	No	< 2.3^3-152	52	Yes^3-151	—^3-151

Recipient	Race	HIV risk	Age	Previous HAART use (start day, in relation to T1 transfusion)^3-150	Log₁₀ HIV viral load	CD4 cells/μL	Detection of male cells after transfusion episode
Recipient	Race	HIV risk	Age		Log₁₀ HIV viral load	CD4 cells/μL	T1	T2
NLR-1	Black	Intravenous drug use	47	No	4.7	6	No	Yes
NLR-2	Black	Intravenous drug use	28	−27	3.3	3	No	Yes
NLR-3	Black	Heterosexual	34	−48	5.0	6	No	Yes
NLR-4	White	Heterosexual	45	No	4.7	10	Yes	No
NLR-5	Black	Heterosexual	44	No	4.7	2	No	Yes
LR-1	White	Heterosexual	31	No	< 2.3^3-152	52	Yes^3-151	—^3-151

Highly active antiretroviral therapy exposure before transfusion.

LR-1 did not undergo T2 transfusion; male cells were detected only in the 3-month posttransfusion sample.

Below lower limit of detection.